Disc Medicine Inc’s recently made public that its Director Bitterman Kevin unloaded Company’s shares for reported $24075.0 on Aug 05 ’25. In the deal valued at $60.95 per share,395 shares were sold. As a result of this transaction, Bitterman Kevin now holds 625,082 shares worth roughly $36.9 million.
Then, Atlas Venture Opportunity Fund bought 395 shares, generating $23,617 in total proceeds.
Before that, Atlas Venture Fund X, L.P. bought 705 shares. Disc Medicine Inc shares valued at $42,152 were divested by the Shareholder at a price of $59.79 per share.
Truist initiated its Disc Medicine Inc [IRON] rating to a Buy in a research note published on July 21, 2025; the price target was $86. TD Cowen started covering the stock on February 27, 2025. It rated IRON as “a Buy”.
Price Performance Review of IRON
On Tuesday, Disc Medicine Inc [NASDAQ:IRON] saw its stock jump 0.75% to $59.03. Over the last five days, the stock has lost -2.96%. Disc Medicine Inc shares have risen nearly 37.76% since the year began. Nevertheless, the stocks have fallen -6.89% over the past one year. While a 52-week high of $68.73 was reached on 01/02/25, a 52-week low of $30.82 was recorded on 04/09/25.
Levels Of Support And Resistance For IRON Stock
The 24-hour chart illustrates a support level at 57.93, which if violated will result in even more drops to 56.84. On the upside, there is a resistance level at 60.25. A further resistance level may holdings at 61.46.
How much short interest is there in Disc Medicine Inc?
A steep rise in short interest was recorded in Disc Medicine Inc stocks on 2025-07-31, dropping by -0.81 million shares to a total of 2.26 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-30 was 3.07 million shares. There was a decline of -35.82%, which implies that there is a negative sentiment for the stock.
